Recall Atlas
Drugs & medicalType I

Mint-Betahistine 8, 16 & 24mg: Data integrity concerns with product's bioequivalence data that could lead to incorrect dosing.

Product quality

Read the official notice →
Date
2024-06-06
Country
Canada
Product
Mint-Betahistine 8, 16 & 24mg
Classification
Type I
Category
Drugs & medical
Source
Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

  1. 2024-06-07
  2. CA
    Drugs & medicalType II

    Beckman Coulter Au Immunochemistry System- Immunoglobulin M (IgM)

    Performance

    Health CanadaOfficial notice →
  3. CA
    Drugs & medicalType II

    NGENUITY 3D Visualization System

    Performance

    Health CanadaOfficial notice →
  4. CA
    Drugs & medicalType II

    Zoll ventilators with MRI compatibility

    Labelling and packaging

    Health CanadaOfficial notice →
  5. 2024-06-06
  6. CA
    Drugs & medicalType II

    Howmedica Revision Instrument System (HRIS) Storage & Sterilization Case and Tray

    Sterility

    Health CanadaOfficial notice →
  7. CA
    Drugs & medicalType II

    Vasoview Hemopro 2 Endoscopic Vessel Harvesting System

    Performance

    Health CanadaOfficial notice →
  8. 2024-06-05
  9. CA
    Drugs & medicalType II

    Deep Brain Stimulation Clinician and Patient Programmer Applications

    Performance

    Health CanadaOfficial notice →
See all drugs & medical recalls →